DIMT1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.302200E-01
Normal-vs-Stage2
2.766600E-01
Normal-vs-Stage3
3.336400E-02
Normal-vs-Stage4
2.758200E-01
Stage1-vs-Stage2
5.301000E-01
Stage1-vs-Stage3
1.361010E-01
Stage1-vs-Stage4
7.375400E-01
Stage2-vs-Stage3
4.901200E-01
Stage2-vs-Stage4
8.120800E-01
Stage3-vs-Stage4
2.046400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.394600E-01
Normal-vs-AfricanAmerican
6.979600E-01
Normal-vs-Asian
1.274610E-01
Caucasian-vs-AfricanAmerican
4.766600E-01
Caucasian-vs-Asian
2.137400E-01
AfricanAmerican-vs-Asian
2.911400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.453400E-01
Normal-vs-Female
2.653800E-01
Male-vs-Female
3.879200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.065600E-02
Normal-vs-Age(41-60Yrs)
4.323000E-01
Normal-vs-Age(61-80Yrs)
2.143000E-01
Normal-vs-Age(81-100Yrs)
4.748200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.168200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.866200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.643200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.349700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.294400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.803600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.767990E-01
Normal-vs-Daily Drinker
1.505630E-01
Normal-vs-Weekly Drinker
3.250200E-01
Normal-vs-Occasional Drinker
9.045900E-02
Normal-vs-Social Drinker
1.593820E-01
Non Drinker-vs-Daily Drinker
7.652400E-01
Non Drinker-vs-Weekly Drinker
9.638400E-01
Non Drinker-vs-Occasional Drinker
9.422800E-01
Non Drinker-vs-Social Drinker
6.363800E-01
Daily Drinker-vs-Weekly Drinker
7.952000E-01
Daily Drinker-vs-Occasional Drinker
8.236400E-01
Daily Drinker-vs-Social Drinker
4.695800E-01
Weekly Drinker-vs-Occasional Drinker
9.273000E-01
Weekly Drinker-vs-Social Drinker
7.613000E-01
Occasional Drinker-vs-Social Drinker
5.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.900000E-01
Normal-vs-Grade 2
7.927700E-02
Normal-vs-Grade 3
5.659000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.249800E-02
Grade 1-vs-Grade 3
2.219000E-01
Grade 1-vs-Grade 4
3.900000E-01
Grade 2-vs-Grade 3
5.163000E-01
Grade 2-vs-Grade 4
7.927700E-02
Grade 3-vs-Grade 4
5.659000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.255400E-01
Normal-vs-NonDiabetic
1.798640E-01
Diabetic-vs-NonDiabetic
7.701000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.323210E-01
Normal-vs-NoPancreatitis
2.265000E-01
Pancreatitis-vs-NoPancreatitis
4.068800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.425200E-01
Normal-vs-N1
2.668800E-01
N0-vs-N1
7.054000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.475590E-01
Normal-vs-TP53-NonMutant
4.550800E-01
TP53-Mutant-vs-TP53-NonMutant
1.495010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
